An analysis from the START study reported that the CD4:CD8 ratio was a better predictor of risk compared to the CD4 count in people with strong immune function.
Paul Sax, M.D., provides a brief rundown of important prevention, treatment and complications research presented at the International AIDS Conference, and whatever else happened to catch his eye.
This Week in HIV Research: Taking Treatment 4 Days a Week Maintains Viral Suppression, and On-Demand PrEP Highly Effective
This week, a study finds that taking antiretroviral therapy from Monday to Thursday, while taking weekends off, maintained undetectable viral loads for the majority of study participants.
Researchers found that certain factors played an important role in reducing survival among HIV-positive people, including co-infection with hepatitis-causing viruses, excessive intake of alcohol, substance use and tobacco smoking.
Even with current HIV treatment, there are still barriers to care and complications. To help identify and address these obstacles, we asked some leading HIV experts and advocates what they think is the most overlooked issue in HIV care today.
A poor socioeconomic score -- largely driven by financial difficulties -- independently doubled chances that HIV-positive adults in France would have a detectable viral load.
Jennifer Johnsen, M.D., M.P.H., provides a broad update on CROI 2015, including developments in treatment, prevention and cure research.
Smoking marijuana was associated with less HIV testing, but didn't affect a patient's journey toward viral suppression, according to a study presented at CROI 2015.
AIDS 2014 has chosen Emirates Airlines as the official airline for the conference. However, the airline is owned by a government rife with HIV stigma. David Duran reports.
If a major study found "zero" cases of HIV transmission among mixed-status couples, why did it also find that the risk was higher than zero?